Copper as Ancillary Diagnostic Tool in Preoperative Evaluation of Possible Papillary Thyroid Carcinoma in Patients with Benign Thyroid Disease

被引:16
|
作者
Dragutinovic, Vesna V. [1 ]
Tatic, Svetislav B. [2 ]
Nikolic-Mandic, Snezana D. [3 ]
Tripkovic, Tatjana M. [4 ]
Dunderovic, Dusko M. [2 ]
Paunovic, Ivan R. [5 ]
机构
[1] Univ Belgrade, Inst Med Chem, Sch Med, Belgrade, Serbia
[2] Univ Belgrade, Inst Pathol, Sch Med, Belgrade, Serbia
[3] Univ Belgrade, Fac Chem, Belgrade, Serbia
[4] Inst Protect Cultural Monuments Serbia, Belgrade, Serbia
[5] Univ Belgrade, Sch Med, Clin Ctr Serbia, Belgrade, Serbia
关键词
Papillary thyroid carcinoma; Benign thyroid disease; Copper; Serum; TRACE-ELEMENTS; BREAST-TISSUE; SERUM COPPER; ZINC; HOMEOSTASIS; CADMIUM; CANCER;
D O I
10.1007/s12011-014-0071-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Preoperative diagnosis of papillary thyroid carcinoma (PTC) comprises numerous diagnostic procedures which are mostly applicable in tertiary institutions. Normal thyroid function depends on the presence of many trace elements and copper (Cu) and zinc (Zn) are some of those. The study is based on retrospective review of 118 patients with preoperatively diagnosed benign thyroid disease (BTD) and 12 with PTC, who underwent thyroid surgery at the Center for Endocrine Surgery Clinical Center of Serbia, Belgrade, between 2010 and 2012. The objective was to evaluate concentrations of Cu and Zn in serum as possible prediction markers for PTC in patients who underwent surgery for preoperatively diagnosed BTD. Concentrations of Cu and Zn ions in serum were measured using atomic absorption spectrophotometer. Data were analyzed using methods of descriptive statistics, Anova and t-test (p < 0.05 was considered statistically significant). Definitive pathohistological findings revealed PTC in 23 (19.5 %) and papillary microcarcinoma-mPTC in 13 (11.0 %) of BTD patients. The concentrations of Cu ions in serum of PTC patients as well as in serum of patients with mPTC were significantly higher than in serum of BTD patients (p < 0.05). The concentrations of Zn ions and Cu/Zn ratio in serum of PTC and mPTC patients were not significantly higher than in serum of BTD patients. The concentration of Cu ions in serum of patients before thyroid surgery can be useful, easy available, and a low-cost tool in prediction of preoperatively undiagnosed PTC in patients with BTD.
引用
收藏
页码:311 / 315
页数:5
相关论文
共 50 条
  • [41] Pancreatic Struma with Papillary Thyroid Carcinoma: a Diagnostic Dilemma
    Jerry Liu
    Michael J. Marcaccio
    J. E. M. Young
    Tariq Aziz
    Josephine Wat
    Sylvia L. Asa
    Endocrine Pathology, 2017, 28 : 91 - 94
  • [42] Nodular Thyroid Disease and Papillary Thyroid Carcinoma in Functional Pituitary Adenomas
    Dogansen, Sema Ciftci
    Yalin, Gulsah Yenidunya
    Tanrikulu, Seher
    Yarman, Sema
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2018, 22 (03) : 158 - 166
  • [43] Prognostic factors for recurrence in patients with papillary thyroid carcinoma
    Tawil, Jose Antonio Hakim
    Rojas, Maria Fernanda
    Santivanez, Juan Jose
    Leon, Leonardo
    Devia, Deyanira Gonzalez
    ENT-EAR NOSE & THROAT JOURNAL, 2023,
  • [44] Incidental Papillary Thyroid Carcinoma: Diagnostic Findings in a Series of 287 Carcinomas
    Pagni, Fabio
    Jaconi, Marta
    Delitala, Alberto
    Garancini, Mattia
    Maternini, Matteo
    Bono, Francesca
    Giani, Alessandro
    Smith, Andrew
    ENDOCRINE PATHOLOGY, 2014, 25 (03) : 288 - 296
  • [45] DIAGNOSTIC VALUE OF DUPLEX DOPPLER ULTRASOUND PARAMETERS IN PAPILLARY THYROID CARCINOMA
    Aslan, A.
    Sancak, S.
    Aslan, M.
    Ayaz, E.
    Inan, I.
    Ozkanli, S. S.
    Alimoglu, O.
    Yikilmaz, A.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2018, 14 (01) : 43 - 48
  • [46] Pancreatic Struma with Papillary Thyroid Carcinoma: a Diagnostic Dilemma
    Liu, Jerry
    Marcaccio, Michael J.
    Young, J. E. M.
    Aziz, Tariq
    Wat, Josephine
    Asa, Sylvia L.
    ENDOCRINE PATHOLOGY, 2017, 28 (01) : 91 - 94
  • [47] Diagnostic Value of TROP2 Expression in Papillary Thyroid Carcinoma
    Saffar, Hana
    Jahanbin, Behnaz
    Ameli, Fereshteh
    Farhang, Fatemeh
    Tavangar, Seyed M.
    Saffar, Hiva
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (03) : 218 - 222
  • [48] Thyroid autoimmune antibodies in patients with papillary thyroid carcinoma: a double-edged sword?
    Shen, Chen-Tian
    Zhang, Xin-Yun
    Qiu, Zhong-Ling
    Sun, Zhen-Kui
    Wei, Wei-Jun
    Song, Hong-Jun
    Luo, Quan-Yong
    ENDOCRINE, 2017, 58 (01) : 176 - 183
  • [49] Clinical implications of pathologic factors after thyroid lobectomy in patients with papillary thyroid carcinoma
    Park, Young Min
    Lee, Doh Young
    Oh, Kyung Ho
    Cho, Jae-Gu
    Baek, Seung-Kuk
    Kwon, Soon-Young
    Jung, Kwang-Yoon
    Woo, Jeong-Soo
    ORAL ONCOLOGY, 2017, 75 : 1 - 5
  • [50] Nrf2 as a novel diagnostic biomarker for papillary thyroid carcinoma
    Wang, Zhiyang
    Li, Jing
    Liu, Ziwei
    Yue, Ling
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2023, 67 (02):